List of bibliographic references indexed by Antiviraux (usage thérapeutique)
Number of relevant bibliographic references: 261.
[0-20] [
0 - 20][
0 - 50][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000312 (2019) |
Chavely Gwladys Monamele [Cameroun] ; Hermann Landry Munshili Njifon [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohamadou Ripa Njankouo [Cameroun] ; Sebastien Kenmoe [Cameroun] ; Ali Ahmed Yahaya ; Louis Deweerdt [Cameroun] ; Raphael Nono [Cameroun] ; Wilfred Mbacham [Cameroun] ; Damian Nota Anong [Cameroun] ; Jane Francis Akoachere [Cameroun] ; Richard Njouom [Cameroun] | Molecular characterization of influenza A(H1N1)pdm09 in Cameroon during the 2014-2016 influenza seasons |
| 000386 (2019) |
Sudhir Venkatesan [Royaume-Uni] ; Jonathan S. Nguyen-Van-Tam [Royaume-Uni] ; Peer-Olaf Siebers [Royaume-Uni] | A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during an influenza pandemic |
| 000457 (2018) |
Lisa M. Koonin ; Anita Patel | Timely Antiviral Administration During an Influenza Pandemic: Key Components |
| 000493 (2018) |
Barbara Jester [Géorgie (pays)] ; Timothy Uyeki [Géorgie (pays)] ; Daniel Jernigan [Géorgie (pays)] | Readiness for Responding to a Severe Pandemic 100 Years After 1918. |
| 000503 (2018) |
César Parra-Rojas ; Van Kinh Nguyen ; Gustavo Hernandez-Mejia ; Esteban A. Hernandez-Vargas | Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day? |
| 000516 (2018) |
Sherif Beniameen Mossad [États-Unis] | Influenza update 2018-2019: 100 years after the great pandemic. |
| 000530 (2018) |
Jiangzhuo Chen [États-Unis] ; Achla Marathe [États-Unis] ; Madhav Marathe [États-Unis] | Feedback Between Behavioral Adaptations and Disease Dynamics |
| 000539 (2018) |
Isabel Lane [Royaume-Uni] ; Ashley Bryce [Royaume-Uni] ; Suzanne M. Ingle [Royaume-Uni] ; Alastair D. Hay [Royaume-Uni] | Does locally relevant, real-time infection epidemiological data improve clinician management and antimicrobial prescribing in primary care? A systematic review |
| 000545 (2018) |
D B C. Wu [Malaisie] ; N. Chaiyakunapruk [Malaisie] ; C. Pratoomsoot [Thaïlande] ; K K C. Lee [Malaisie] ; H Y Chong [Malaisie] ; R E Nelson [États-Unis] ; P F Smith [États-Unis] ; C M Kirkpatrick [Australie] ; M A Kamal [États-Unis] ; K. Nieforth [États-Unis] ; G. Dall [États-Unis] ; S. Toovey [Suisse] ; D C M. Kong [Australie] ; A. Kamauu [États-Unis] ; C R Rayner [États-Unis] | Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. |
| 000683 (2017) |
Hana M. Dobrovolny [États-Unis, Canada] ; Catherine A. A. Beauchemin [Canada, Japon] | Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms |
| 000688 (2017) |
Mohamed A. Kamal ; Patrick F. Smith ; Nathorn Chaiyakunapruk ; David B. C. Wu ; Chayanin Pratoomsoot ; Kenneth K. C. Lee ; Huey Yi Chong ; Richard E. Nelson ; Keith Nieforth ; Georgina Dall ; Stephen Toovey ; David C. M. Kong ; Aaron Kamauu ; Carl M. Kirkpatrick ; Craig R. Rayner | Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics |
| 000844 (2016) |
Robert Moss [Australie] ; James M. Mccaw [Australie] ; Allen C. Cheng [Australie] ; Aeron C. Hurt [Australie] ; Jodie Mcvernon [Australie] | Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context |
| 000851 (2016) |
Amalya Mangiri ; A. Danielle Iuliano ; Yunita Wahyuningrum ; Catharina Y. Praptiningsih ; Kathryn E. Lafond ; Aaron D. Storms ; Gina Samaan ; Iwan Ariawan ; Nugroho Soeharno ; Jennifer M. Kreslake ; J. Douglas Storey ; Timothy M. Uyeki | Physician's knowledge, attitudes, and practices regarding seasonal influenza, pandemic influenza, and highly pathogenic avian influenza A (H5N1) virus infections of humans in Indonesia |
| 000911 (2016) |
Emi Takashita [Japon] ; Miho Ejima [Japon] ; Rie Ogawa [Japon] ; Seiichiro Fujisaki [Japon] ; Gabriele Neumann [États-Unis] ; Yousuke Furuta [Japon] ; Yoshihiro Kawaoka [Japon] ; Masato Tashiro [Japon] ; Takato Odagiri [Japon] | Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir. |
| 000A91 (2015) |
Martin I. Meltzer [Géorgie (pays)] ; Manoj Gambhir [Australie, Géorgie (pays)] ; Charisma Y. Atkins [Géorgie (pays)] ; David L. Swerdlow | Standardizing Scenarios to Assess the Need to Respond to an Influenza Pandemic |
| 000B17 (2015) |
Sylvie Skalickova ; Zbynek Heger [République tchèque] ; Ludmila Krejcova ; Vladimir Pekarik ; Karel Bastl ; Jozef Janda ; Frantisek Kostolansky ; Eva Vareckova ; Ondrej Zitka [République tchèque] ; Vojtech Adam [République tchèque] ; Rene Kizek [République tchèque] | Perspective of Use of Antiviral Peptides against Influenza Virus |
| 000B23 (2015) |
Nicola L. Bird [Australie] ; Matthew R. Olson [Australie] ; Aeron C. Hurt [Australie] ; Christine M. Oshansky [États-Unis] ; Ding Yuan Oh [Australie] ; Patrick C. Reading [Australie] ; Brendon Y. Chua [Australie] ; Yilun Sun [États-Unis] ; Li Tang [États-Unis] ; Andreas Handel [États-Unis] ; David C. Jackson [Australie] ; Stephen J. Turner [Australie] ; Paul G. Thomas [États-Unis] ; Katherine Kedzierska [Australie] | Oseltamivir Prophylaxis Reduces Inflammation and Facilitates Establishment of Cross-Strain Protective T Cell Memory to Influenza Viruses |
| 000B31 (2015) |
Wenjiao Wu ; Dongguo Lin ; Xintian Shen ; Fangfang Li ; Yuxin Fang ; Kaiqun Li ; Tianrong Xun ; Guang Yang ; Jie Yang ; Shuwen Liu ; Jian He | New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides |
| 000B33 (2015) |
Milan Sencanski ; Draginja Radosevic ; Vladimir Perovic ; Branislava Gemovic ; Maja Stanojevic ; Nevena Veljkovic ; Sanja Glisic [Serbie] | Natural Products as Promising Therapeutics for Treatment of Influenza Disease. |
| 000B96 (2015) |
Norio Sugaya [Japon] ; Yuko Sakai-Tagawa ; Masahiro Bamba ; Rieko Yasuhara ; Masahiko Yamazaki ; Chiharu Kawakami ; Yoshio Yamaguchi ; Yoshiaki Ide ; Masataka Ichikawa ; Keiko Mitamura ; Yoshihiro Kawaoka [États-Unis] | Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor. |
| 000B99 (2015) |
Andres Hagerman [Suisse] ; Klara M. Posfay-Barbe [Suisse] ; Andrea Duppenthaler [Suisse] ; Ulrich Heininger [Suisse] ; Christoph Berger [Suisse] | Clinical characteristics and outcomes in children hospitalised with pandemic influenza A/H1N1/09 virus infection – a nationwide survey by the Pediatric Infectious Diseases Group of Switzerland. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Antiviraux (usage thérapeutique)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Antiviraux (usage thérapeutique)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Antiviraux (usage thérapeutique)
}}
| This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021 |  |
